BACKGROUND A lower heart rate is associated with better outcomes in patients with heart failure (HF) with
H eart failure (HF) is a leading cause of cardiovascular morbidity and mortality (1) . Heart rate has emerged as a powerful independent predictor of outcome in patients with HF with reduced ejection fraction (HFrEF) and therapeutic interventions targeted at lowering heart rate have been shown to improve outcomes in these patients (2) (3) (4) (5) . However, less is known about the association of heart rate and outcomes in patients with HF with preserved ejection fraction (HFpEF), which constitute nearly one-half of all HF patients (6, 7) . The objective of the current study was to examine the associations of heart rate with outcomes in patients with HFpEF.
METHODS

We used data from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in
Hospitalized Patients with Heart Failure) registry, a national hospital-based registry, the details of which have been previously described (7, 8) . Briefly, Admission and discharge heart rates (in beats/min) were estimated by palpation, telemetry, and electrocardiogram for patients with sinus rhythm and atrial fibrillation, as appropriate (8) . To minimize bias due to possible measurement errors or acute inpatient clinical instability, we restricted our analysis to patients with stable heart rates, defined as admission to discharge heart rate variation of #20 beats/min. Of the 6,286 patients with a stable heart rate, 2,369 (38%) had a discharge heart rate of <70 beats/min ( Figure 1 ). We used a heart rate cutoff of 70 beats/min to define low heart rate, given that a heart rate SEE PAGE 1872
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<70 beats/min has been shown to be associated with improved cardiovascular outcomes in patients with HFrEF (2, 3, 5) .
ASSEMBLY OF COHORTS. We used propensity scores to assemble a matched cohort in which patients with a discharge heart rate <70 versus $70 beats/min would be balanced on key measured baseline characteristics (10) (11) (12) . A multivariable logistic regression model was used to estimate propensity scores for discharge heart rate <70 beats/min for each of the 6,286 patients using 58 baseline characteristics displayed in Figure 2 (13) (14) (15) (16) . Using a matching algorithm described elsewhere (17), we matched 2,031 patients with a heart rate <70 beats/min with 2,031 patients with heart rate $70 beats/min to assemble a matched cohort of 4,062 patients ( Figure 1A ). Between-group balance for each of the 58 baseline characteristics was assessed using absolute standardized differences, and the results were presented as a Love plot ( Figure 2 ) (18).
To determine whether the associations observed in our primary cohort could be replicated using different approaches, we assembled 3 sensitivity cohorts. First, to determine whether the association of discharge heart rate <70 beats/min and outcomes could be replicated without excluding those with an unstable heart rate (admission-to-discharge heart rate variation >20 beats/min), we repeated the process in 8,783 patients with valid data on discharge heart rate, Heart rate ≥70 bpm (n = 7,741)
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Heart Rate and Outcomes in HFpEF assembling 4,796 propensity score-matched patients (2,398 pairs) with discharge heart rate <70 versus $70 beats/min ( Figure 1B) . Then, to determine whether the association could be replicated using admission heart rate <70 beats/min, we repeated the process in 8,778 patients with valid data on admission heart rate regardless of admission-to-discharge heart rate variations, assembling 5,870 matched patients (2,935 pairs) with an admission heart rate <70
versus $70 beats/min ( Figure 1C) . Finally, to determine whether the findings of our primary cohort could be replicated using a different EF cutoff, we repeated the process in 7,412 patients with EF >40% and stable heart rate, assembling 5,418 matched patients (2,709 pairs) with a discharge heart rate <70 versus $70 beats/min ( Figure 1D ). This Love plot displays absolute standardized differences comparing 58 baseline characteristics of 6,286 pre-match and 4,062 propensity score-matched patients with heart failure with preserved ejection fraction ($50%) by heart rate <70 versus $70 beats/min. An absolute standardized difference of 0%
indicates no residual bias and values <10% indicate inconsequential bias. ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blockers.
Lam et al.
Heart Rate and Outcomes in HFpEF Values are mean AE SD or n (%). *Heart rate is the exposure variable and would not be expected to be balanced in the matched cohort; presented for descriptive purposes only.
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker.
Heart Rate and Outcomes in HFpEF were conducted using matched data. Kaplan-Meier survival analysis was used to generate plots for all-cause mortality by discharge heart rate (<70 vs.
$70 beats/min). Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) associated with heart rate and survival time (time to event). For mortality, we used time to death for patients who died and time to study end as censoring time for those who did not die. For readmissions, we used time to readmission for patients who had a readmission, and time to death or time to study end, whichever occurred first, as censoring time for those without a readmission. We also fit Fine and Gray's proportional subdistribution hazards models to examine the association of heart rate (<70 vs. $70 beats/min) with all-cause readmission in the presence of the competing risk of mortality (19, 20) . To assess nonlinearity in the relationship between discharge heart rate as a continuous variable and all-cause mortality, we fitted restricted cubic spline models with 3 knots at heart rates of 60, 70 (reference), and 100 beats/min in the pre-match data, adjusting for propensity scores, as well as in the matched data. Formal sensitivity analyses were conducted to quantify the degree of a hidden bias that could potentially explain away any significant association in our primary matched cohort (21, 22) . Subgroup analyses were conducted to determine the homogeneity of the association of discharge heart rate <70 beats/min and all-cause mortality in our primary matched cohort. All statistical tests 
RESULTS
The 4,062 matched patients had a mean age of 79 AE 10 years, EF of 59 AE 7%, and discharge heart rate of 71 AE 12 beats/min; 66% were women, and 10% African
American. Of these, 3,455 patients (85%) had a normal discharge heart rate (60 to 100 beats/min), 1,343 (33%) had a history of atrial fibrillation, and 2,611 (64%) received a discharge prescription for beta-blockers.
Before matching, patients with a discharge heart rate <70 beats/min had a higher mean age, and a greater proportion of these patients were white and had hypertension, coronary artery disease, and diabetes ( Table 1) . These and other measured baseline characteristics were balanced after matching, and the absolute standardized difference for all 58 baseline characteristics was <10%, suggesting no consequential between-group differences (Table 1, Figure 2 ). Mean admission and discharge heart rates for the 2 heart rate groups, before and after matching, are displayed in Table 1 . Table 2 , Central Illustration).
In the absence of hidden bias, a sign-score test for matched data with censoring provided strong evidence that patients with a discharge heart rate <70 beats/min outlived those with a heart rate $70 beats/min (p < 0.001). Findings of our subgroup analyses demonstrated that the beneficial association between heart rate <70 beats/min and all-cause mortality was homogenous across various clinically relevant subgroups of patients, including those by baseline atrial fibrillation and beta-blocker use ( Figure 3) . Findings from our restricted cubic spline analysis demonstrated no evidence of a nonlinear relationship between heart rate and all-cause mortality (p > 0.2 for test for nonlinearity in both prematch and matched data) and that the risk was significantly lower at heart rate <70 beats/min and was significantly higher at heart rate $70 beats/min ( Figure 4) .
Among the 4,796 matched patients with EF $50%
with a valid discharge heart rate that included patients with unstable inpatient heart rate, all-cause mortality occurred in 66% and 70% of patients with a discharge heart rate <70 beats/min versus Lam et al.
Heart Rate and Outcomes in HFpEF with EF $50% with valid admission heart rate that included patients with unstable inpatient heart rate, all-cause mortality occurred in 66% and 70% of patients with an admission heart rate <70 beats/min versus $70 beats/min, respectively (HR: 0.88; 95% CI:
0.83 to 0.94; p < 0.001). Among the 5,418 matched patients with EF >40% and stable heart rate, all-cause mortality occurred in 66% and 70% of patients with a discharge heart rate <70 beats/min versus $70 beats/min, respectively (HR: 0.88; 95% CI: 0.82 to 0.94; p < 0.001).
DISCHARGE HEART RATE AND OTHER OUTCOMES.
Among the 4,062 matched patients with EF $50% and stable heart rate, a discharge heart rate <70 beats/min was associated with a lower rate of the combined endpoint of HF readmission or all-cause mortality, but had no association with all-cause readmission or HF readmission ( Table 2) . A discharge heart rate <70 beats/min had no significant association 
DISCUSSION
Findings from our study demonstrated that among hospitalized patients with HFpEF, a discharge heart rate of <70 beats/min was associated with a significantly lower risk of all-cause mortality. A heart rate <70 beats/min also was associated with a lower risk of the combined endpoint of HF readmission or all-cause mortality. However, a lower heart rate had no This study assessed the association of discharge heart rate with outcomes in patients with heart failure (HF) with preserved ejection fraction (HFpEF), assembling a primary analysis cohort of 2,031 pairs of propensity score-matched patients with a discharge heart rate of <70 versus $70 beats/min.
Propensity score-matched patients in the primary analysis cohort as well as in 3 sensitivity analyses cohorts with a heart rate <70 beats/min had a significantly lower risk of all-cause mortality compared with those with a heart rate $70 beats/min. The lower heart rate also was associated with a lower risk of a combination of HF readmission or all-cause mortality, but not of either HF or all-cause readmission separately.
Heart Rate and Outcomes in HFpEF significant association with HF or all-cause readmission. To the best of our knowledge, this is the first study to demonstrate a beneficial association between a lower heart rate and subsequent long-term outcomes in 4 separate propensity score-matched cohorts of patients with HFpEF from a national HF registry using different EF cutoffs and heart rate criteria.
There are several potential explanations for our findings. A lower resting heart rate would be expected to be a marker of attenuated sympathetic tone and, consequently, lower levels of atherogenesis, myocardial ischemia, and left ventricular dysfunction (23-27).
However, before matching, we found that patients with a heart rate <70 beats/min had a significantly higher prevalence of coronary artery disease, prior myocardial infarction and coronary revascularization, and a significantly higher proportion of these patients were receiving angiotensin-converting enzyme inhibitors and beta-blockers. It is possible that the higher use of beta-blockers in patients with a heart rate <70 beats/min was in part driven by the higher prevalence of coronary artery disease in that group.
Thus, an intrinsically attenuated sympathetic tone would be unlikely to explain the lower mortality in patients with a heart rate <70 beats/min in our study. In all variables analyzed, patients with lower heart rates had lower rates of mortality compared to patients with heart rates $70 beats/min. CI ¼ confidence interval.
Heart Rate and Outcomes in HFpEF
However, a heart rate <70 beats/min was also associated with a lower risk of death in patients not receiving beta-blockers, suggesting a potential beneficial role of an intrinsically attenuated sympathetic tone. An attenuated sympathetic tone would also be expected to reduce pro-arrhythmic propensity and sudden cardiac death, a relatively more common mode of cardiovascular death (versus pump failure death) in patients with HFpEF (28, 29) . Sudden cardiac deaths outside the hospital would preclude readmission, which might in part explain the higher risk of death, but not of readmission, in the higher heart rate group in our study.
Several prior studies have examined the association of heart rate with outcomes in HFpEF (6, 30, 31) .
However, these studies are limited by small sample size, single sex, inclusion of both HFrEF and HFpEF, and use of trial-eligible younger patients. By contrast, our study was distinguished by a national cohort of real-world older patients, the use of an EF cutoff of 50% to define HFpEF, the use of propensity score matching to assemble a balanced cohort, the use of subgroup analyses to demonstrate homogeneity, the use of multiple sensitivity analyses to demonstrate robustness of association, and the use of formal sensitivity analyses to assess bias by a potential unmeasured confounder.
Our study has important clinical implications.
These findings suggest that a higher heart rate is a marker of poor prognosis in patients with HFpEF and that it might be an independent risk factor for mortality. These findings might tempt one to suggest that a discharge prescription of beta-blockers or other heart rate-lowering drugs might be beneficial. Findings from our subgroup analysis suggest that a lower heart rate was associated with lower mortality regardless of use of beta-blockers. However, it remains unclear whether a reduction of heart rate in patients with HFpEF and a higher heart rate through initiation or up-titration of the dose of beta-blockers would be associated with improved outcomes (32, 33) . Findings to date from heart rate-lowering interventions, including beta-blockers, in HFpEF have not found any evidence of clinical benefit (34-38). However, many of these studies were limited by small sample size, use of surrogate endpoints, and inclusion of patients with a normal heart rate. Future prospective studies need to examine this association in the high-risk subset of HFpEF patients with elevated heart rate.
STUDY LIMITATIONS. Despite propensity score matching, bias due to an unmeasured confounder was possible. However, findings from our sensitivity In cubic spline analysis, no nonlinear relationship between heart rate and all-cause mortality was found in either (A) 6,286 pre-match patients, adjusting for propensity scores, or (B) 4,062 matched patients balanced on 58 baseline characteristics (nonlinearity p > 0.20 for both pre-match and matched data). *Spline curves truncated at heart rate ¼ 120 beats/min (9 pre-match patients and none of the matched patients had a heart rate >120 beats/min).
Solid orange lines represent hazard ratios, and light orange shaded areas represent 95% CIs. Light gray rectangles ¼ normal heart rate range of 60 to 100 beats/min. CI ¼ confidence interval. analysis suggest that the beneficial association of a heart rate <70 beats/min and all-cause mortality was rather insensitive to a hidden bias. A hidden covariate could explain away this association if it would also increase the odds of having a heart rate <70 beats/min by about 8%. However, it is an unlikely possibility: for an imaginary unmeasured binary covariate to become a confounder, it would also need to be a near perfect predictor of mortality and could not be strongly correlated to any of the 58 variables used in our propensity score model. We had no data on heart rate before hospital admission. If baseline characteristics were affected by the prevalent heart rate, it might potentially underestimate true associations. Finally, our analysis was restricted to fee-for-service Medicare beneficiaries, which might limit generalizability.
CONCLUSIONS
In hospitalized older patients with HFpEF, a discharge heart rate <70 beats/min was independently associated with a lower risk of all-cause mortality, but had no association with all-cause or HF readmission. These findings suggest that the beneficial association of a lower heart rate and Heart Rate and Outcomes in HFpEF O C T O B E R 1 0 , 2 0 1 7 : 1 8 6 1 -7 1
